Literature DB >> 12151566

Surveillance in Barrett's oesophagus: a personal view.

K K Basu1, J S de Caestecker.   

Abstract

Barrett's oesophagus is defined as columnar-lined oesophagus of any length containing specialised intestinal metaplasia. Diagnosis depends on close corroboration between the endoscopist and histopathologist. It occurs in 10% of patients presenting endoscopically with reflux symptoms and has an adenocarcinoma incidence of 0.4% to 2%. Surveillance is performed to detect precancerous change (dysplasia) and early stage disease has a good surgical prognosis. Computer models suggest cost efficacy comparable to other health measures. However most patients with Barrett's do not die of oesophageal cancer and elective oesophagectomy has an appreciable mortality. Endoscopic ablation techniques and improved definition of high risk subgroups will help shape future surveillance programmes.

Entities:  

Mesh:

Year:  2002        PMID: 12151566      PMCID: PMC1742368          DOI: 10.1136/pmj.78.919.263

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  94 in total

1.  The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.

Authors:  D J Drewitz; R E Sampliner; H S Garewal
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

2.  Changing patterns and surgical results in adenocarcinoma of the oesophagus.

Authors:  P Thomas; C Doddoli; P Lienne; N Morati; X Thirion; L Garbe; R Giudicelli; P Fuentes
Journal:  Br J Surg       Date:  1997-01       Impact factor: 6.939

3.  Barrett's esophagus: should we brush off this ballooning problem?

Authors:  S J Spechler
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

Review 4.  Risk factors for neoplastic progression in Barrett's mucosa.

Authors:  M B Menke-Pluymers
Journal:  Eur J Surg Oncol       Date:  1996-08       Impact factor: 4.424

5.  Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology.

Authors:  G W Falk; R Chittajallu; J R Goldblum; C V Biscotti; K R Geisinger; R E Petras; S Birgisson; T W Rice; J E Richter
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

6.  Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.

Authors:  A van der Burgh; J Dees; W C Hop; M van Blankenstein
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

7.  Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus.

Authors:  A P Weston; P T Krmpotich; R Cherian; A Dixon; M Topalosvki
Journal:  Am J Gastroenterol       Date:  1997-03       Impact factor: 10.864

8.  p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia.

Authors:  M Younes; A Ertan; L V Lechago; J R Somoano; J Lechago
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

9.  National Cancer Data Base report on esophageal carcinoma.

Authors:  J M Daly; L H Karnell; H R Menck
Journal:  Cancer       Date:  1996-10-15       Impact factor: 6.860

10.  Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus.

Authors:  M I Canto; S Setrakian; R E Petras; E Blades; A Chak; M V Sivak
Journal:  Gastrointest Endosc       Date:  1996-07       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.